{"changes":[],"country":"US","description":"Stipple Bio is a biotech company developing targeted cancer therapies by identifying tumor-specific molecular epitopes that standard discovery methods miss. It serves cancer patients needing more precise therapeutic targeting. Its differentiator is a stippling method that maps subtle epitope differences invisible to traditional antibody discovery.","domain":"stipplebio.com","employees":null,"founded":2022,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":42.365635,"lng":-71.104002,"location":"Cambridge, US","name":"Stipple Bio","rounds":[{"amountQuarantined":false,"amountUsd":100000000,"currency":"USD","date":"2026-04-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-04-30","status":"attributed","url":null},"status":"attributed","type":"series-a","url":null}],"slug":"stipplebio-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-04-30","status":"attributed","url":null},{"fact":"existence","publisher":"stipplebio.com","retrievedAt":"2026-04-30","status":"self-reported","url":"https://stipplebio.com"},{"fact":"description","publisher":"stipplebio.com","retrievedAt":"2026-04-30","status":"self-reported","url":"https://stipplebio.com"}],"stage":"series-a","techStack":[],"totalRaisedUsd":100000000,"updatedAt":"2026-04-30"}